Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 ...Middle East

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China , July 25, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and...

Hence then, the article about harbour biomed to present the latest progress of the first in class fully human anti b7h7 hhla2 monoclonal antibody hbm1020 at the esmo congress 2024 was published today ( Friday 26/07/2024 - 05:32 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed to Present the Latest Progress of the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024 )

Also on site :

• Pentagon wants killer AI without safeguards – Reuters
• '90s Grunge Rock Band's Hits Revived in Special Tribute Performance
• Paul Rudd Reveals the Unexpected Reason Why He Almost Lost His ‘Clueless’ Role